NuVasive (NUVA) Reports In-Line Q3 EPS; Offers Guidance
Tweet
Share
E-mail
Get Alerts NUVA Hot Sheet
Price: $39.75 --0%
Financial Fact:
Total operating expenses: 159.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 159.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
NuVasive (NASDAQ: NUVA) reported Q3 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $295.3 million versus the consensus estimate of $298.74 million.
GUIDANCE:
NuVasive sees FY2022 EPS of $0.50-$0.60, versus the consensus of $2.24.
For earnings history and earnings-related data on NuVasive (NUVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- UBS says bull market has further to run
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
